Biggest News Aggregation in the World
📰 Deep Track News

Deep Track News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Deep Track. Real-time updates on events, politics, business and more.

Carmot's IPO Filing Makes Case for Bias in Drugging Key Obesity, Diabetes Targets

Carmot Therapeutics isn’t the first company targeting both the GLP-1 and GIP receptors to treat metabolic diseases. But the company contends that biased signaling—activating certain pathways but not others—is key to setting its drugs apart from others in the same class.
United States Novo Nordisk Victoza Novo Nordisk Ozempic Eli Lilly Stig Hansen Heather Turner

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science